{"doc_id": "si-2020-0177-reg-1", "parent_doc_id": "si-2020-0177", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 2) Regulations 2020. \n\n(2) The citation “the Medicinal Products (Prescription and Control of \n\nSupply) Regulations 2003 to 2020” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 2) regulation 2020 (2) citation medicinal product (prescription control supply) regulation 2003 2020 includes regulation", "start_char": 637, "end_char": 916, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
{"doc_id": "si-2020-0177-reg-2", "parent_doc_id": "si-2020-0177", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "2. The Medicinal Products (Prescription and Control of Supply)", "text_raw": "2. The Medicinal Products (Prescription and Control of Supply) \nRegulations 2003 (S.I. No. 540 of 2003) are amended by substituting for the \nSeventh Schedule (as amended by Regulation 4 of the Medicinal Products \n(Prescription and Control of Supply) (Amendment) Regulations 2014 (S.I. No. \n300 of 2014)) the following: \n\n“Seventh Schedule \n\nPart 1 \n\nMedicinal Products which may be supplied to pre-hospital emergency care \n\nproviders for use by advanced paramedics \n\n(Regulation 20(8) (a)) \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 22nd May, 2020. \n\n \n \n \n \n \n \n \n \n \n\f[177] 3 \n\nMedicinal Product \n\nRoute of \nAdministration \n\nConditions of \nAdministration \n\nAuthority to \nAdminister \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nActivated Charcoal Oral \n\nAdults and children: \n\nPoisoning. \n\nAdenosine Solution \nfor Injection \n\nIntravenous \n\nAdults: \n\nSupraventricular \ntachycardias (SVT). \n\nAminophylline \n\nIntravenous \n\nAdults and children: \n\nAcute severe asthma. \n\nAmiodarone \nInjection \n\nIntravenous \n\nAdults and children: \n\nCardiac arrest \n\nTachyarrhythmia. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAspirin (various \noral dosage forms) \n\nOral \n\nAdults: \n\nAcute Cardiac \nSyndrome \n\nDecompression \nillness. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n\f4 [177] \n\nAtropine Injection \n\nIntravenous \n\nAdults and children: \n\nEndotracheal \n\nCardiac arrest, \n\nBradycardia, \n\nPoisoning. \n\nBenzylpenicillin \nInjection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSuspected or \nconfirmed sepsis. \n\nCalcium Gluconate \n10% \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nHypotension, \n\nHyperkalaemia, \n\nCardiac arrest, \n\nCalcium Channel \nblocker toxicity, \n\nHydrofluoric acid. \ninhalation. \n\nCalcium Gluconate \nGel \n\nTopical \n\nAdults and children: \n\nHydrofluoric acid \nburns. \n\nCefotaxime Powder \nfor Injection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSuspected or \nconfirmed sepsis. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n\fCeftriaxone Powder \nfor Injection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSuspected or \nconfirmed sepsis. \n\nChlorphenamine \nInjection (otherwise \nChlorpheniramine \nInjection) \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nAllergic reactions, \nAnaphylaxis. \n\nChlorphenamine \n(otherwise \nChlorpheniramine) \n(various oral \ndosage forms) \n\nOral \n\nAdults and children: \n\nAllergic reaction, \nAnaphylaxis. \n\nClopidogrel Tablets Oral \n\nAdults: \n\nAcute Coronary \nSyndrome. \n\n[177] 5 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nCyclizine Injection \n\nIntramuscular \nIntravenous \n\nAdults and children: \n\nTo prevent or treat \nopiate induced \nnausea and \nvomiting, \n\nAnti emetic. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nDexamethasone \nPhosphate solution \n\nOral \n\nIntramuscular \nIntravenous \n\nChildren: \n\nCroup. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n \n\f6 [177] \n\nDexamethasone \n\nOral \n\n(various oral \ndosage forms) \n\nChildren: \n\nCroup. \n\nDextrose 5% \nSolution for \nInfusion \n\nIntravenous \n\nAdults and children: \n\nDilutant for \nmedications. \n\nDextrose 10% \nSolution for \nInfusion \n\nIntravenous \n\nAdults and children: \n\nHypoglycaemia, \n\nDilutant for \nmedications. \n\nDiazepam Injection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSeizures, \n\nSedation. \n\nDiazepam Rectal \nSolution \n\nPer rectum \n\nAdults and children: \n\nSeizures. \n\nDobutamine (12.5 \nmg/ml) Concentrate \nfor Infusion \n\nIntravenous \n\nAdults and children: \n\nSeptic shock, \n\nCardiogenic shock. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n\fDopamine \nHydrochloride (40 \nmg/ml) Concentrate \nfor Infusion \n\nEnoxaparin Sodium \nSolution for \nInjection \n\nIntravenous \n\nAdults and children: \n\nCardiogenic shock. \n\nIntravenous \n\nAdults: \n\nSubcutaneous \n\nST- elevation \nmyocardial \ninfarction \n(STEMI). \n\nEpinephrine \n(Adrenaline) \n\n1 mg/1ml (1:1000) \n\nInjection \n\nIntramuscular \n\nAdults and children: \n\nAnaphylaxis, \n\nBronchospasm. \n\nEpinephrine \n(Adrenaline) \n(1:1000) for \nNebulisation \n\nInhalation \n\nChildren: \n\nCroup, \n\nAsthma. \n\nEpinephrine \n(Adrenaline) \n\n1 mg/10 ml (1:10 \n000) Solution for \nInjection \n\nIntravenous \n\nAdults and children: \n\nEndotracheal \n\nCardiac arrest, \n\nBradycardia, \n\n Anaphylaxis, \n\nSevere hypotension. \n\nErgometrine \nInjection 500 \nmcg/ml \n\nIntravenous \nIntramuscular \n\nAdults: \n\nPost partum \nhaemorrhage. \n\n[177] 7 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n\f8 [177] \n\nFentanyl Citrate \n(100 mcg in 2 ml) \n\nIntravenous \nIntranasal \n\nBuccal \n\nAdults and children: \n\nPain management, \n\nSedation. \n\nFurosemide \nInjection \n\nIntravenous \n\nAdults: \n\nIntramuscular \n\nPulmonary \noedema. \n\nGlucagon for \nInjection \n\nIntramuscular \n\nAdults and children: \n\nSubcutaneous \n\nHypoglycaemia. \n\nGlyceryl Trinitrate \nAerosol \n\nSublingual \n\nAdults: \n\nCardiac chest pain, \n\nCongestive heart \nfailure. \n\nGlycopyrronium \nBromide \n\nSubcutaneous \n\nAdults and children: \n\nOropharyngeal \nsecretions. \n\nHaloperidol \n\nOral \n\nAdults: \n\nNausea & \nVomiting, \n\nDelirium/Agitation. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n\fHaloperidol \nInjection 5 mg/ml \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSedation, \n\nSubcutaneous \n\nNausea & \nvomiting, \n\nHartmann’s \nSolution for \nInfusion \n\nIntravenous \n\nDelirium/ agitation. \n\nAdults and children: \nHypovolaemic \nshock, \nAnaphylaxis, \n\n Decompression \n\nillness, \n\n Cardiac arrest, \n\n Bradycardia, \n\n Dilutant for \nmedications. \n\nHeparin Sodium \nSolution for \nInjection \n\nIntravenous \n\nAdults and children: \n\nDeep vein \nthrombosis, \n\nPulmonary \nembolism, \n\nUnstable angina, \n\nAcute peripheral \narterial occlusion. \n\nHydrocortisone \nPowder for \nSolution for \nInjection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nBronchospasm, \n\nAnaphylaxis, \n\nAddison’s disease. \n\nHydromorphone \nhydrochloride \n\nSubcutaneous \n\nAdults: \n\nPain. \n\n[177] 9 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\n \n \n \n \n \n \n \n\f10 [177] \n\nHydromorphone \nhydrochloride \n\nOral \n\nAdults: \n\nPain. \n\nHydroxocobalamin \nPowder for \nSolution for \nInjection \n\nHyoscine \nButylbromide \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nCyanide poisoning. \n\nSubcutaneous \n\nAdults and children: \n\nAbdominal colic \n\nOropharyngeal \nsecretions. \n\nHyoscine \nHydrobromide \n\nSubcutaneous \n\nAdults and children: \n\nOropharyngeal \nsecretions. \n\nIbuprofen (various \noral dosage forms) \n\nOral \n\nAdults and children: \n\nPain. \n\nIbuprofen \nsuppositories \n\nPer rectum \n\nChildren: \n\nPain. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n\fInfluenza Vaccines \n\nIntramuscular \n\nAdults and children: \n\nProphylaxis for \ninfluenza infection. \n\nIpratropium \nBromide Nebuliser \nSolution \n\nInhalation \n\nAdults and children: \n\nBronchospasm. \n\nKetamine \nHydrochloride \nInjection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSedation, \n\nIntranasal \n\nPain. \n\nLidocaine \nHydrochloride \nInjection \n\nIntravenous \n\nAdults: \n\nEndotracheal \n\nCardiac arrest, \n\nSubcutaneous \n\nLocal anaesthetic, \n\nTopical \n\nJelly fish sting, \n\nIO infusion. \n\nLidocaine \nHydrochloride \nspray 4% \n\nTopical \n\nLocal anaesthetic, \n\nJelly fish sting. \n\nLidocaine \nHydrochloride Gel", "text_norm": "2 medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) amended substituting seventh schedule (as amended regulation 4 medicinal product (prescription control supply) (amendment) regulation 2014 (s.i no 300 2014)) following seventh schedule part 1 medicinal product may supplied pre-hospital emergency care provider use advanced paramedic (regulation 20(8) (a)) notice making statutory instrument published iris oifigiuil 22nd may 2020 177 3 medicinal product route administration condition administration authority administer column 1 column 2 column 3 column 4 activated charcoal oral adult child poisoning adenosine solution injection intravenous adult supraventricular tachycardia (svt) aminophylline intravenous adult child acute severe asthma amiodarone injection intravenous adult child cardiac arrest tachyarrhythmia according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction aspirin (various oral dosage forms) oral adult acute cardiac syndrome decompression illness according cpg registered medical practitioner instruction 4 177 atropine injection intravenous adult child endotracheal cardiac arrest bradycardia poisoning benzylpenicillin injection intravenous adult child intramuscular suspected confirmed sepsis calcium gluconate 10 intravenous adult child intramuscular hypotension hyperkalaemia cardiac arrest calcium channel blocker toxicity hydrofluoric acid inhalation calcium gluconate gel topical adult child hydrofluoric acid burn cefotaxime powder injection intravenous adult child intramuscular suspected confirmed sepsis according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction ceftriaxone powder injection intravenous adult child intramuscular suspected confirmed sepsis chlorphenamine injection (otherwise chlorpheniramine injection) intravenous adult child intramuscular allergic reaction anaphylaxis chlorphenamine (otherwise chlorpheniramine) (various oral dosage forms) oral adult child allergic reaction anaphylaxis clopidogrel tablet oral adult acute coronary syndrome 177 5 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction cyclizine injection intramuscular intravenous adult child prevent treat opiate induced nausea vomiting anti emetic according cpg registered medical practitioner instruction dexamethasone phosphate solution oral intramuscular intravenous child croup according cpg registered medical practitioner instruction 6 177 dexamethasone oral (various oral dosage forms) child croup dextrose 5 solution infusion intravenous adult child dilutant medication dextrose 10 solution infusion intravenous adult child hypoglycaemia dilutant medication diazepam injection intravenous adult child intramuscular seizure sedation diazepam rectal solution per rectum adult child seizure dobutamine (12.5 mg ml) concentrate infusion intravenous adult child septic shock cardiogenic shock according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction dopamine hydrochloride (40 mg ml) concentrate infusion enoxaparin sodium solution injection intravenous adult child cardiogenic shock intravenous adult subcutaneous st- elevation myocardial infarction (stemi) epinephrine (adrenaline) 1 mg 1ml (1 1000) injection intramuscular adult child anaphylaxis bronchospasm epinephrine (adrenaline) (1 1000) nebulisation inhalation child croup asthma epinephrine (adrenaline) 1 mg 10 ml (1 10 000) solution injection intravenous adult child endotracheal cardiac arrest bradycardia anaphylaxis severe hypotension ergometrine injection 500 mcg ml intravenous intramuscular adult post partum haemorrhage 177 7 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 8 177 fentanyl citrate (100 mcg 2 ml) intravenous intranasal buccal adult child pain management sedation furosemide injection intravenous adult intramuscular pulmonary oedema glucagon injection intramuscular adult child subcutaneous hypoglycaemia glyceryl trinitrate aerosol sublingual adult cardiac chest pain congestive heart failure glycopyrronium bromide subcutaneous adult child oropharyngeal secretion haloperidol oral adult nausea vomiting delirium agitation according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction haloperidol injection 5 mg ml intravenous adult child intramuscular sedation subcutaneous nausea vomiting hartmann solution infusion intravenous delirium agitation adult child hypovolaemic shock anaphylaxis decompression illness cardiac arrest bradycardia dilutant medication heparin sodium solution injection intravenous adult child deep vein thrombosis pulmonary embolism unstable angina acute peripheral arterial occlusion hydrocortisone powder solution injection intravenous adult child intramuscular bronchospasm anaphylaxis addison disease hydromorphone hydrochloride subcutaneous adult pain 177 9 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 10 177 hydromorphone hydrochloride oral adult pain hydroxocobalamin powder solution injection hyoscine butylbromide intravenous adult child intramuscular cyanide poisoning subcutaneous adult child abdominal colic oropharyngeal secretion hyoscine hydrobromide subcutaneous adult child oropharyngeal secretion ibuprofen (various oral dosage forms) oral adult child pain ibuprofen suppository per rectum child pain according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction influenza vaccine intramuscular adult child prophylaxis influenza infection ipratropium bromide nebuliser solution inhalation adult child bronchospasm ketamine hydrochloride injection intravenous adult child intramuscular sedation intranasal pain lidocaine hydrochloride injection intravenous adult endotracheal cardiac arrest subcutaneous local anaesthetic topical jelly fish sting io infusion lidocaine hydrochloride spray 4 topical local anaesthetic jelly fish sting lidocaine hydrochloride gel", "start_char": 916, "end_char": 11095, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
{"doc_id": "si-2020-0177-reg-2", "parent_doc_id": "si-2020-0177", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "Topical", "text_raw": "2.5%. \n\nTopical \n\nLocal anaesthetic, \n\nJelly fish sting. \n\n[177] 11 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n \n\f12 [177] \n\nLorazepam \nInjection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSeizures, \n\nSedation. \n\nLorazepam Tablets Oral \n\nAdults and children: \n\nSedation. \n\nMagnesium \nSulphate Injection \nBP \n\nIntravenous \n\nAdults and children: \n\nCardiac arrest, \n\nBronchospasm, \n\nPre eclampsia, \n\nStroke. \n\nMeropenem \nPowder for \nInjection \n\nIntravenous \n\nAdults and children: \n\nSuspected or \nconfirmed sepsis. \n\nMethoxyflurane for \nInhalation \n\nBy inhalation \n\nAdults: \n\nPain relief in \nconscious adult \npatients with \ntrauma and \nassociated pain. \n\nMethylprednisolone \nSodium Succinate \nPowder for \nInjection \n\nIntramuscular \nIntravenous \n\nAdults and children: \n\nBronchial \ninflammation. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\fMetoclopramide \nSolution for \nInjection \n\nIntramuscular \nIntravenous \n\n[177] 13 \n\nAdults and children: \n\nTo prevent or treat \nopiate induced \nnausea and \nvomiting, \n\nAnti emetic. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nMidazolam \nSolution for \nInjection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSeizures, \n\nIntranasal \n\nSedation. \n\nSubcutaneous \n\nMidazolam \nSolution (Buccal) \n\nBuccal \n\nAdults and children: \n\nSeizures. \n\nMorphine Injection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSubcutaneous \n\nModerate to severe \npain. \n\nMorphine Oral \nSolution \n\nOral \n\nAdults and children: \n\nPain. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f14 [177] \n\nNaloxone for \nInjection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSubcutaneous \n\nIntranasal \n\nRespiratory \ndepression \nsecondary to known \nor suspected \nnarcotic overdose. \n\nNifedipine \nCapsules \n\nOral \n\nAdults: \n\nInhibition of labour. \n\nMedical gas \nmixture consisting \nof 50% nitrous \noxide and 50% \noxygen \n\nNoradrenaline \n(Norepinephrine) \nAcid Tartrate \n(1:1000) \nConcentrate for \nSolution for \nInjection \n\nOndansetron \nHydrochloride \n\nBy inhalation \n\nAdults and children: \n\nPain relief. \n\nIntravenous \ninfusion \n\nAdults and children: \n\n Acute hypotension. \n\nOral \n\nAdults and children: \n\nNausea, \n\nVomiting. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\n \n \n \n \n \n \n \n \n \n \n\f[177] 15 \n\nOndansetron \n\nHydrochloride \nInjection \n\nIntramuscular \nIntravenous \n\nSubcutaneous \n\nIntranasal \n\nAdults and children: \n\nTo prevent or treat \nopiate induced \nnausea and \nvomiting, \n\nAnti-emetic. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nOseltamivir \nCapsules \n\nOral \n\nAdults and children: \n\nTreatment of \ninfluenza. \n\nOseltamivir Powder \nfor Oral Suspension \n\nOral \n\nAdults and children: \n\nTreatment of \ninfluenza. \n\nOxycodone IR \ntablets \n\nOral \n\nAdults and children: \n\nPain, \n\nDyspnoea. \n\nOxycodone IR for \ninjection \n\nSubcutaneous \n\nAdults and children: \n\nPain, \n\nDyspnoea. \n\nOxygen medical \ngas \n\nBy inhalation \n\nAdults and children: \n\nHypoxia. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n\f16 [177] \n\nOxytocin Solution \nfor Injection \n\nIntravenous \nIntramuscular \n\nAdults: \n\nPost partum \nhaemorrhage. \n\nParacetamol \nsuppositories \n\nPer rectum \n\nChildren: \n\nPyrexia, \n\nPain. \n\nParacetamol \n(various oral \ndosage forms) \n\nParacetamol IV \nsolution \n\nOral \n\nAdults and children: \n\nPain, \n\nPyrexia. \n\nIntravenous \n\nAdults and children: \n\nPain, \n\nPyrexia. \n\nPipercillin \ntazobactum \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSuspected or \nconfirmed sepsis. \n\nPrasugrel Tablets \n\nOral \n\nAdults: \n\nAcute Coronary \nSyndrome. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n\fPrednisolone \nTablets \n\nOral \n\nAdults and children: \n\nAnti-inflammatory, \n\nAllergic conditions, \n\nAcute asthma. \n\nRocuronium \nbromide \n\nIntravenous \n\nAdults and children: \n\nSedation. \n\nSalbutamol for \nNebulisation \n\nInhalation \n\nAdults and children: \n\nBronchospasm in \nanaphylaxis, and \nacute asthma. \n\nSalbutamol Inhaled \nAerosol \n\nInhalation \n\nAdults and children: \n\nBronchospasm in \nanaphylaxis, and \nacute asthma. \n\nSalbutamol for \ninjection \n\nIntravenous \n\nAdults and children: \n\nAnaphylaxis, \n\nacute asthma. \n\nSodium \nBicarbonate \nInjection BP \n\nIntravenous \n\nAdults and children: \n\nCrush injury, \n\nPoisoning, \n\nCardiac arrest. \n\n[177] 17 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n\f18 [177] \n\nSodium Chloride", "text_norm": "2.5  topical local anaesthetic jelly fish sting 177 11 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 12 177 lorazepam injection intravenous adult child intramuscular seizure sedation lorazepam tablet oral adult child sedation magnesium sulphate injection bp intravenous adult child cardiac arrest bronchospasm pre eclampsia stroke meropenem powder injection intravenous adult child suspected confirmed sepsis methoxyflurane inhalation inhalation adult pain relief conscious adult patient trauma associated pain methylprednisolone sodium succinate powder injection intramuscular intravenous adult child bronchial inflammation according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction metoclopramide solution injection intramuscular intravenous 177 13 adult child prevent treat opiate induced nausea vomiting anti emetic according cpg registered medical practitioner instruction midazolam solution injection intravenous adult child intramuscular seizure intranasal sedation subcutaneous midazolam solution (buccal) buccal adult child seizure morphine injection intravenous adult child intramuscular subcutaneous moderate severe pain morphine oral solution oral adult child pain according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 14 177 naloxone injection intravenous adult child intramuscular subcutaneous intranasal respiratory depression secondary known suspected narcotic overdose nifedipine capsule oral adult inhibition labour medical gas mixture consisting 50 nitrous oxide 50 oxygen noradrenaline (norepinephrine) acid tartrate (1 1000) concentrate solution injection ondansetron hydrochloride inhalation adult child pain relief intravenous infusion adult child acute hypotension oral adult child nausea vomiting according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 177 15 ondansetron hydrochloride injection intramuscular intravenous subcutaneous intranasal adult child prevent treat opiate induced nausea vomiting anti-emetic according cpg registered medical practitioner instruction oseltamivir capsule oral adult child treatment influenza oseltamivir powder oral suspension oral adult child treatment influenza oxycodone ir tablet oral adult child pain dyspnoea oxycodone ir injection subcutaneous adult child pain dyspnoea oxygen medical gas inhalation adult child hypoxia according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 16 177 oxytocin solution injection intravenous intramuscular adult post partum haemorrhage paracetamol suppository per rectum child pyrexia pain paracetamol (various oral dosage forms) paracetamol iv solution oral adult child pain pyrexia intravenous adult child pain pyrexia pipercillin tazobactum intravenous adult child intramuscular suspected confirmed sepsis prasugrel tablet oral adult acute coronary syndrome according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction prednisolone tablet oral adult child anti-inflammatory allergic condition acute asthma rocuronium bromide intravenous adult child sedation salbutamol nebulisation inhalation adult child bronchospasm anaphylaxis acute asthma salbutamol inhaled aerosol inhalation adult child bronchospasm anaphylaxis acute asthma salbutamol injection intravenous adult child anaphylaxis acute asthma sodium bicarbonate injection bp intravenous adult child crush injury poisoning cardiac arrest 177 17 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 18 177 sodium chloride", "start_char": 11095, "end_char": 18173, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
{"doc_id": "si-2020-0177-reg-0", "parent_doc_id": "si-2020-0177", "section_id": "reg-0", "section_label": "Regulation 0.", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "0.9% for Infusion", "text_raw": "0.9% for Infusion \n\nIntravenous \n\nAdults and children: \n\nAnaphylaxis, \n\nBradycardia, \n\nBurns, \n\nCannula flush, \n\nCardiac Arrest, \n\nCrush injury, \n\nDecompression \nillness, \n\nDehydration, \n\nDilutant for \nmedications, \nHyperglycaemia, \n\nHypothermia, \n\nHypovolaemic \nshock, \n\nTo keep vein open. \n\nSuccinylated \nGelatin Solution for \ninfusion \n\nIntravenous \n\nAdults and children: \n\nHypovolaemia. \n\nSuxamethonium \nChloride \n\nIntravenous \n\nAdults and children: \n\nSedation. \n\nTenecteplase \nPowder for \nInjection \n\nIntravenous \n\nAdults: \n\nST- elevation \nmyocardial \ninfarction (STEMI). \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n\fTetanus \nImmunoglobulin \n\nIntramuscular \n\nAdults and Children: \n\nPost exposure \nprophylaxis and \ntreatment of \ntetanus infection. \n\nTetracaine Gel 4% Topical \n\nAdults and children: \n\nAnaesthesia prior to \nvenepuncture. \n\nTetracaine \nHydrochloride", "text_norm": "0.9 infusion intravenous adult child anaphylaxis bradycardia burn cannula flush cardiac arrest crush injury decompression illness dehydration dilutant medication hyperglycaemia hypothermia hypovolaemic shock keep vein open succinylated gelatin solution infusion intravenous adult child hypovolaemia suxamethonium chloride intravenous adult child sedation tenecteplase powder injection intravenous adult st- elevation myocardial infarction (stemi) according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction tetanus immunoglobulin intramuscular adult child post exposure prophylaxis treatment tetanus infection tetracaine gel 4 topical adult child anaesthesia prior venepuncture tetracaine hydrochloride", "start_char": 18173, "end_char": 19323, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
{"doc_id": "si-2020-0177-reg-0", "parent_doc_id": "si-2020-0177", "section_id": "reg-0", "section_label": "Regulation 0.", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "0.5% w/v Eye", "text_raw": "0.5% w/v Eye \nDrops \n\nTopical \n\nAdults and children: \n\nConjunctival \nanaesthesia. \n\nTerbutaline \nSulphate Metered \nDose Powder \nInhaler \n\nInhalation \n\nAdults: \n\nInhibition of \nlabour. \n\nTerbutaline \nSulphate 0.5mg/ml \nSolution for \nInjection or \nInfusion \n\nIntravenous \n\nAdults: \n\nSubcutaneous \n\nInhibition of \nlabour. \n\nThiamine Injection \n\nIntravenous \n\nAdults: \n\nIntramuscular \n\nUnresponsive \npatients with long \nterm alcohol abuse, \n\nDelirium tremens. \n\n[177] 19 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n\f20 [177] \n\nTicagrelor tablets \n\nOral \n\nAdults: \n\nAcute Coronary \nSyndrome. \n\nTramadol \nHydrochloride 50 \nmg Capsules \n\nOral \n\nAdults and children: \n\nPain. \n\nTranexamic Acid \n500 mg/5 ml \nSolution for \nInjection or \nInfusion \n\nIntravenous \n\nAdults and children: \n\nHaemorrhagic \nshock, \n\nEpistaxis. \n\nVasopressin \nInjection \n\nIntravenous \n\nAdults and children: \n\nSeptic shock, \n\n Cardiogenic shock. \n\nZanamivir \nInhalation Powder \n\nInhalation \n\nAdults and children: \n\nTreatment of \ninfluenza. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[177] 21 \n\nPart 2 \n\nMedicinal products which may be supplied to pre-hospital emergency care \n\nproviders for use by paramedics \n\n(Regulation 20(8)(b)) \n\nMedicinal \nProduct \n\nRoute of \nAdministration \n\nConditions of \nAdministration \n\nAuthority to \nAdminister \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nActivated Charcoal Oral \n\nAdults and children: \n\nPoisoning. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAspirin (various \noral dosage forms) \n\nOral \n\nAdults: \n\nAcute Cardiac \nSyndrome, \n\nDecompression \nillness. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nBenzylpenicillin \nInjection \n\nIntramuscular \n\nAdults and children: \n\nSuspected or \nconfirmed \nmeningococcal \nsepsis. \n\nCalcium Gluconate \ngel \n\nTopical \n\nAdults and children: \n\nHydrofluoric acid \nburns. \n\nChlorphenamine \nInjection \n(otherwise \nChlorpheniramine \nInjection) \n\nIntramuscular \n\nAdults and children: \n\nAllergic reactions, \n\nAnaphylaxis. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n\f22 [177] \n\n Chlorphenamine \n(various oral \ndosage forms) \n\nOral \n\nAdults and children: \n\nAllergic reactions, \n\nAnaphylaxis. \n\nClopidogrel \nTablets \n\nOral \n\nAdults: \n\nAcute Coronary \nSyndrome. \n\nCyclizine Injection \n\nIntramuscular \n\nAdults and children: \n\nTo prevent or treat \nopiate induced \nnausea and \nvomiting, \n\nAnti-emetic. \n\nDexamethasone \nPhosphate solution \n\nIntramuscular \n\nChildren: \n\nCroup. \n\nDexamethasone \n\nOral \n\n(various oral \ndosage forms) \n\nChildren: \n\nCroup. \n\nDextrose 10% \nSolution for \nInfusion \n\nIntravenous \n\nAdults and children: \n\nHypoglycaemia. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n\fDiazepam Rectal \nSolution \n\nPer rectum \n\nAdults and children: \n\nSeizure. \n\nIntramuscular \n\nAdults and children: \n\nAnaphylaxis. \n\nIntravenous \n\nAdults and children: \n\nCardiac arrest. \n\nEpinephrine \n(Adrenaline) \n\n1 mg/1 ml (1:1 \n000) – Injection \n\nEpinephrine \n(Adrenaline) \n\n1 mg/10 ml (1:10 \n000) Solution for \nInjection \n\nFentanyl Citrate \n(100 mcg in 2 ml) \n\nIntranasal \n\nAdults and children: \n\nBuccal \n\nPain management. \n\nGlucagon for \nInjection \n\nIntramuscular \nSubcutaneous \n\nAdults and children: \n\nHypoglycaemia. \n\nGlyceryl Trinitrate \nAerosol \n\nSublingual \n\nAdults: \n\nCardiac chest pain, \n\nCongestive heart \nfailure. \n\n[177] 23 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n\f24 [177] \n\nGlycopyrronium \nBromide \n\nSubcutaneous \n\nAdults and children: \n\nOropharyngeal \nsecretions. \n\nHaloperidol \n\nOral \n\nAdults: \n\nHartmann’s \nSolution for \nInfusion \n\nIntravenous \n\nNausea & \nVomiting, \n\nDelirium/Agitation. \n\nAdults and children: \nHypovolaemic \nshock, \nAnaphylaxis, \n\n Decompression \n\nillness, \n\n Burns, \n\n Cardiac arrest, \n\n Bradycardia, \n\n Dilutant for \nmedications. \n\n. \n\nHydromorphone \nhydrochloride \n\nSubcutaneous \n\nAdults: \n\nPain. \n\nHydromorphone \nhydrochloride \n\nOral \n\nAdults: \n\nPain. \n\nHydrocortisone \nPowder for \nSolution for \nInjection \n\nIntramuscular \n\nAdults and children: \n\nAnaphylaxis, \n\nAddison’s disease. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstruction \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\n \n \n \n \n\fHydroxocobalamin \nPowder for \nSolution for \nInjection \n\nIntramuscular \n\nAdults and children: \n\nCyanide poisoning. \n\nHyoscine \nButylbromide \n\nSubcutaneous \n\nAdults and children: \n\nAbdominal colic, \n\nOropharyngeal \nsecretions. \n\nHyoscine \nHydrobromide \n\nSubcutaneous \n\nAdults and children: \n\nOropharyngeal \nsecretions. \n\nIbuprofen (various \noral dosage forms) \n\nOral \n\nAdults and children: \n\nPain. \n\nIbuprofen \nsuppositories \n\nPer rectum \n\nChildren: \n\nPain. \n\nInfluenza Vaccines \n\nIntramuscular \n\nAdults and children: \n\nProphylaxis for \ninfluenza infection. \n\n[177] 25 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\n \n \n \n \n \n\f26 [177] \n\nIpratropium \nBromide Nebuliser \nSolution \n\nInhalation \n\nAdults and children: \n\nBronchospasm. \n\nMethoxyflurane \nfor Inhalation \n\nBy inhalation \n\nAdults: \n\nPain relief in \nconscious adult \npatients with trauma \nand associated pain. \n\nMidazolam \nSolution for \nInjection \n\nIntranasal \n\nAdults and children: \n\nIntramuscular \n\n Seizures, \n\nSubcutaneous \n\nPalliative sedation. \n\nMidazolam \nSolution (Buccal) \n\nBuccal \n\nAdults and children: \n\n Seizures. \n\nMorphine Injection \n\nIntravenous \n\nAdults and children: \n\nIntramuscular \n\nSubcutaneous \n\nModerate to severe \npain. \n\nNaloxone for \nInjection \n\nIntramuscular \n\nAdults and children: \n\nSubcutaneous \n\nIntranasal \n\nRespiratory \ndepression \nsecondary to \nknown or suspected \nnarcotic overdose. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nOn \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\fMedical gas \nmixture consisting \nof 50% nitrous \noxide and 50% \noxygen \n\nOndansetron \nHydrochloride \n\nBy inhalation \n\nAdults and children: \n\nPain relief. \n\nOral \n\nAdults and children: \n\nNausea, \n\nVomiting. \n\nOndansetron \nHydrochloride \nInjection \n\nIntramuscular \n\nAdults and children: \n\nSubcutaneous \nIntranasal \n\nTo prevent or treat \nopiate induced \nnausea and \nvomiting, \n\nAnti-emetic. \n\nOseltamivir \nCapsules \n\nOral \n\nAdults and children: \n\nTreatment of \ninfluenza. \n\nOseltamivir \nPowder for Oral \nSuspension \n\nOral \n\nAdults and children: \n\nTreatment of \ninfluenza. \n\nOxycodone IR \ntablets \n\nOral \n\nAdults and children: \n\nPain, \n\ndyspnoea. \n\n[177] 27 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n\f28 [177] \n\nOxycodone IR for \ninjection \n\nSubcutaneous \n\nAdults and children: \n\nPain, \n\ndyspnoea. \n\nOxygen medical \ngas \n\nBy inhalation \n\nAdults and children: \n\nHypoxia. \n\nOxytocin Solution \nfor Injection \n\nIntramuscular \n\nAdults: \n\nPost partum \nhaemorrhage. \n\nParacetamol \nsuppositories \n\nPer rectum \n\nChildren: \n\nPyrexia, \n\nPain. \n\nParacetamol \n(various oral \ndosage forms) \n\nOral \n\nAdults and children: \n\nPain, \n\nPyrexia. \n\nPrasugrel Tablets \n\nOral \n\nAdults: \n\nAcute Coronary \nSyndrome. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n\f[177] 29 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nPrednisolone \nTablets \n\nSalbutamol for \nNebulisation \n\nOral \n\nAdults and children: \n\nInflammatory \ndisorder, \n\nAllergic disorder, \n\nAcute asthma. \n\nInhalation \n\nAdults and children: \n\nBronchospasm in \nanaphylaxis and \nacute asthma. \n\nSalbutamol \nInhaled Aerosol \n\nInhalation \n\nAdults and children: \n\nBronchospasm in \nanaphylaxis, and \nacute asthma. \n\nSodium Chloride", "text_norm": "0.5 w v eye drop topical adult child conjunctival anaesthesia terbutaline sulphate metered dose powder inhaler inhalation adult inhibition labour terbutaline sulphate 0.5mg ml solution injection infusion intravenous adult subcutaneous inhibition labour thiamine injection intravenous adult intramuscular unresponsive patient long term alcohol abuse delirium tremens 177 19 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 20 177 ticagrelor tablet oral adult acute coronary syndrome tramadol hydrochloride 50 mg capsule oral adult child pain tranexamic acid 500 mg 5 ml solution injection infusion intravenous adult child haemorrhagic shock epistaxis vasopressin injection intravenous adult child septic shock cardiogenic shock zanamivir inhalation powder inhalation adult child treatment influenza according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 177 21 part 2 medicinal product may supplied pre-hospital emergency care provider use paramedic (regulation 20(8)(b)) medicinal product route administration condition administration authority administer column 1 column 2 column 3 column 4 activated charcoal oral adult child poisoning according cpg registered medical practitioner instruction aspirin (various oral dosage forms) oral adult acute cardiac syndrome decompression illness according cpg registered medical practitioner instruction benzylpenicillin injection intramuscular adult child suspected confirmed meningococcal sepsis calcium gluconate gel topical adult child hydrofluoric acid burn chlorphenamine injection (otherwise chlorpheniramine injection) intramuscular adult child allergic reaction anaphylaxis according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 22 177 chlorphenamine (various oral dosage forms) oral adult child allergic reaction anaphylaxis clopidogrel tablet oral adult acute coronary syndrome cyclizine injection intramuscular adult child prevent treat opiate induced nausea vomiting anti-emetic dexamethasone phosphate solution intramuscular child croup dexamethasone oral (various oral dosage forms) child croup dextrose 10 solution infusion intravenous adult child hypoglycaemia according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction diazepam rectal solution per rectum adult child seizure intramuscular adult child anaphylaxis intravenous adult child cardiac arrest epinephrine (adrenaline) 1 mg 1 ml (1 1 000) - injection epinephrine (adrenaline) 1 mg 10 ml (1 10 000) solution injection fentanyl citrate (100 mcg 2 ml) intranasal adult child buccal pain management glucagon injection intramuscular subcutaneous adult child hypoglycaemia glyceryl trinitrate aerosol sublingual adult cardiac chest pain congestive heart failure 177 23 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 24 177 glycopyrronium bromide subcutaneous adult child oropharyngeal secretion haloperidol oral adult hartmann solution infusion intravenous nausea vomiting delirium agitation adult child hypovolaemic shock anaphylaxis decompression illness burn cardiac arrest bradycardia dilutant medication  hydromorphone hydrochloride subcutaneous adult pain hydromorphone hydrochloride oral adult pain hydrocortisone powder solution injection intramuscular adult child anaphylaxis addison disease according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction hydroxocobalamin powder solution injection intramuscular adult child cyanide poisoning hyoscine butylbromide subcutaneous adult child abdominal colic oropharyngeal secretion hyoscine hydrobromide subcutaneous adult child oropharyngeal secretion ibuprofen (various oral dosage forms) oral adult child pain ibuprofen suppository per rectum child pain influenza vaccine intramuscular adult child prophylaxis influenza infection 177 25 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 26 177 ipratropium bromide nebuliser solution inhalation adult child bronchospasm methoxyflurane inhalation inhalation adult pain relief conscious adult patient trauma associated pain midazolam solution injection intranasal adult child intramuscular seizure subcutaneous palliative sedation midazolam solution (buccal) buccal adult child seizure morphine injection intravenous adult child intramuscular subcutaneous moderate severe pain naloxone injection intramuscular adult child subcutaneous intranasal respiratory depression secondary known suspected narcotic overdose according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction registered medical practitioner instruction according cpg registered medical practitioner instruction medical gas mixture consisting 50 nitrous oxide 50 oxygen ondansetron hydrochloride inhalation adult child pain relief oral adult child nausea vomiting ondansetron hydrochloride injection intramuscular adult child subcutaneous intranasal prevent treat opiate induced nausea vomiting anti-emetic oseltamivir capsule oral adult child treatment influenza oseltamivir powder oral suspension oral adult child treatment influenza oxycodone ir tablet oral adult child pain dyspnoea 177 27 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 28 177 oxycodone ir injection subcutaneous adult child pain dyspnoea oxygen medical gas inhalation adult child hypoxia oxytocin solution injection intramuscular adult post partum haemorrhage paracetamol suppository per rectum child pyrexia pain paracetamol (various oral dosage forms) oral adult child pain pyrexia prasugrel tablet oral adult acute coronary syndrome according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 177 29 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction prednisolone tablet salbutamol nebulisation oral adult child inflammatory disorder allergic disorder acute asthma inhalation adult child bronchospasm anaphylaxis acute asthma salbutamol inhaled aerosol inhalation adult child bronchospasm anaphylaxis acute asthma sodium chloride", "start_char": 19323, "end_char": 30783, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
{"doc_id": "si-2020-0177-reg-0", "parent_doc_id": "si-2020-0177", "section_id": "reg-0", "section_label": "Regulation 0.", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "0.9% for Infusion", "text_raw": "0.9% for Infusion \n\nIntravenous \n\nAdults and children: \n\nAnaphylaxis, \n\nBradycardia, \n\nBurns, \n\nCannula flush, \n\nCardiac Arrest, \n\nCrush injury, \n\nDecompression \nillness, \n\nDehydration, \n\nDilutant for \nmedications, \nHyperglycaemia, \n\nHypothermia, \n\nHypovolaemic \nshock, \n\nTo keep vein open. \n\n \n \n \n \n \n\f30 [177] \n\nTetanus \nImmunoglobulin \n\nIntramuscular \n\nAdults and children: \n\nPost exposure \nprophylaxis and \ntreatment of tetanus \ninfection. \n\nTetracaine Gel 4% Topical \n\nAdults and children: \n\nAnaesthesia prior \nto venepuncture. \n\nTetracaine \nHydrochloride", "text_norm": "0.9 infusion intravenous adult child anaphylaxis bradycardia burn cannula flush cardiac arrest crush injury decompression illness dehydration dilutant medication hyperglycaemia hypothermia hypovolaemic shock keep vein open 30 177 tetanus immunoglobulin intramuscular adult child post exposure prophylaxis treatment tetanus infection tetracaine gel 4 topical adult child anaesthesia prior venepuncture tetracaine hydrochloride", "start_char": 30783, "end_char": 31346, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
{"doc_id": "si-2020-0177-reg-0", "parent_doc_id": "si-2020-0177", "section_id": "reg-0", "section_label": "Regulation 0.", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "0.5% w/v Eye", "text_raw": "0.5% w/v Eye \nDrops \n\nTopical \n\nAdults and children: \n\nConjunctival \nanaesthesia. \n\nTicagrelor tablets Oral \n\nAdults: \n\nAcute Coronary \nSyndrome. \n\nTramadol \nHydrochloride 50 \nmg Capsules \n\nOral \n\nAdults and children: \n\nSevere pain. \n\nZanamivir \nInhalation Powder \n\nInhalation \n\nAdults and children: \n\nTreatment of \ninfluenza. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n\f[177] 31 \n\nPART 3 \n\nMedicinal products which may be supplied to pre-hospital emergency care \n\nproviders for use by emergency medical technicians \n\n(Regulation 20 (8)(c)) \n\nMedicinal \nProduct \n\nRoute of \nAdministration \n\nConditions of \nAdministration \n\nAuthority to \nAdminister \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nActivated \nCharcoal \n\nOral \n\nAdults and \nchildren: \n\nPoisoning. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAdults: \n\nAspirin (various \noral dosage \nforms) \n\nOral \n\nAcute Cardiac \nSyndrome \n\nDecompression \nillness. \n\nCalcium \nGluconate Gel \n\nTopical \n\nAdults and \nchildren: \n\nHydrofluoric \nacid burns. \n\nIntramuscular \n\nAdults and \nchildren: \n\nChlorphenamine \nInjection \n(otherwise \nChlorpheniramine \nInjection) \n\nChlorphenamine \n(various oral \ndosage forms) \n\nOral \n\nAllergic \nreaction, \nAnaphylaxis. \n\nAdults and \nchildren: \n\nAllergic \nreaction, \nAnaphylaxis. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n\f32 [177] \n\nCyclizine \nInjection \n\nIntramuscular \n\nAdults and \nchildren: \n\nTo prevent or \ntreat opiate \ninduced nausea \nand vomiting. \n\nDexamethasone \nPhosphate \nsolution \n\nIntramuscular \n\nChildren: \n\nCroup. \n\nDexamethasone \n\nOral \n\n(various oral \ndosage forms) \n\nChildren: \n\nCroup. \n\nIntramuscular \n\nAdults and \nchildren: \nAnaphylaxis. \n\nIntramuscular \n\nAdults and \nchildren: \n\nAnaphylaxis. \n\nEpinephrine \n(Adrenaline) \n\n1 mg/1 ml \n(1:1000) \n\nInjection \n\nEpinephrine \n(Adrenaline) \ninjection 1 mg/1 \nml (1:1000) \n\n- prefilled \n\ndisposable \nsyringe (auto) \n\nGlucagon for \nInjection \n\nIntramuscular \nSubcutaneous \n\nAdults and \nchildren: \n\nHypoglycaemia. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n\fGlyceryl \nTrinitrate Aerosol \n\nSublingual \n\nAdults: \n\nCardiac chest \npain. \n\nGlycopyrronium \nBromide \n\nSubcutaneous \n\nAdults and \nchildren: \n\nOropharyngeal \nsecretions. \n\nHyoscine \nHydrobromide \n\nSubcutaneous \n\nAdults and \nchildren: \n\nOropharyngeal \nsecretions. \n\nIbuprofen \n(various oral \ndosage forms) \n\nOral \n\nAdults and \nchildren: \n\nPain. \n\nInfluenza \nVaccines \n\nIntramuscular \n\nAdults and \nChildren: \n\nProphylaxis for \ninfluenza \ninfection. \n\nMethoxyflurane \nfor Inhalation \n\nBy inhalation \n\nAdults: \n\nPain relief in \nconscious adult \npatients with \ntrauma and \nassociated pain. \n\n[177] 33 \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n\f34 [177] \n\nMidazolam \nSolution for \nInjection \n\nIntramuscular \n\nSubcutaneous \n\nIntranasal \n\nMidazolam \nSolution (Buccal) \n\nBuccal \n\nAdults and \nchildren: \n\n Palliative \nsedation, \n\nSeizures. \n\nAdults and \nchildren: \n\n Seizures. \n\nMorphine \nInjection \n\nIntravenous \n\nIntramuscular \n\nSubcutaneous \n\nAdults and \nchildren: \n\nModerate or \nsevere pain. \n\nNaloxone for \nInjection \n\nIntramuscular \n\nSubcutaneous \n\nIntranasal \n\nBy inhalation \n\nMedical gas \nmixture \nconsisting of 50% \nnitrous oxide and \n50% oxygen \n\nAdults and \nchildren: \n\nRespiratory \ndepression \nsecondary to \nknown or \nsuspected \nnarcotic \noverdose. \n\nAdults and \nchildren: \n\nPain relief. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[177] 35 \n\nOndansetron \nHydrochloride \n\nOral \n\nOndansetron \n\nIntramuscular \n\nHydrochloride \nInjection \n\nIntranasal \n\nOxygen medical \ngas \n\nBy inhalation \n\nParacetamol \n(various oral \ndosage forms) \n\nOral \n\nAdults and \nchildren: \n\nNausea, \n\nVomiting. \n\nAdults and \nchildren: \n\nTo prevent or \ntreat opiate \ninduced nausea \nand vomiting, \n\nAnti-emetic. \n\nAdults and \nchildren: \n\nHypoxia. \n\nAdults and \nchildren: \n\nPain, \n\nPyrexia. \n\nSalbutamol for \nNebulisation \n\nInhalation \n\nAdults and \nchildren: \n\nBronchospasm \nin anaphylaxis \nand acute \nasthma. \n\nSalbutamol \nInhaled Aerosol \n\nInhalation \n\nAdults and \nchildren: \n\nBronchospasm \nin anaphylaxis \nand acute \nasthma. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n \n \n \n \n \n \n \n\f36 [177] \n\nTetanus \nImmunoglobulin \n\nIntramuscular \n\nAdults and \nchildren: \n\nPost exposure \nprophylaxis and \ntreatment of \ntetanus \ninfection. \n\nAccording to \nCPG or on \nregistered \nmedical \npractitioner’s \ninstructions. \n\n”. \n\nGIVEN under my Official Seal, \n\n15 May, 2020. \n\nSIMON HARRIS, \n\nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n \n\f[177] 37", "text_norm": "0.5 w v eye drop topical adult child conjunctival anaesthesia ticagrelor tablet oral adult acute coronary syndrome tramadol hydrochloride 50 mg capsule oral adult child severe pain zanamivir inhalation powder inhalation adult child treatment influenza according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 177 31 part 3 medicinal product may supplied pre-hospital emergency care provider use emergency medical technician (regulation 20 (8)(c)) medicinal product route administration condition administration authority administer column 1 column 2 column 3 column 4 activated charcoal oral adult child poisoning according cpg registered medical practitioner instruction adult aspirin (various oral dosage forms) oral acute cardiac syndrome decompression illness calcium gluconate gel topical adult child hydrofluoric acid burn intramuscular adult child chlorphenamine injection (otherwise chlorpheniramine injection) chlorphenamine (various oral dosage forms) oral allergic reaction anaphylaxis adult child allergic reaction anaphylaxis according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 32 177 cyclizine injection intramuscular adult child prevent treat opiate induced nausea vomiting dexamethasone phosphate solution intramuscular child croup dexamethasone oral (various oral dosage forms) child croup intramuscular adult child anaphylaxis intramuscular adult child anaphylaxis epinephrine (adrenaline) 1 mg 1 ml (1 1000) injection epinephrine (adrenaline) injection 1 mg 1 ml (1 1000) - prefilled disposable syringe (auto) glucagon injection intramuscular subcutaneous adult child hypoglycaemia according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction glyceryl trinitrate aerosol sublingual adult cardiac chest pain glycopyrronium bromide subcutaneous adult child oropharyngeal secretion hyoscine hydrobromide subcutaneous adult child oropharyngeal secretion ibuprofen (various oral dosage forms) oral adult child pain influenza vaccine intramuscular adult child prophylaxis influenza infection methoxyflurane inhalation inhalation adult pain relief conscious adult patient trauma associated pain 177 33 according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 34 177 midazolam solution injection intramuscular subcutaneous intranasal midazolam solution (buccal) buccal adult child palliative sedation seizure adult child seizure morphine injection intravenous intramuscular subcutaneous adult child moderate severe pain naloxone injection intramuscular subcutaneous intranasal inhalation medical gas mixture consisting 50 nitrous oxide 50 oxygen adult child respiratory depression secondary known suspected narcotic overdose adult child pain relief according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 177 35 ondansetron hydrochloride oral ondansetron intramuscular hydrochloride injection intranasal oxygen medical gas inhalation paracetamol (various oral dosage forms) oral adult child nausea vomiting adult child prevent treat opiate induced nausea vomiting anti-emetic adult child hypoxia adult child pain pyrexia salbutamol nebulisation inhalation adult child bronchospasm anaphylaxis acute asthma salbutamol inhaled aerosol inhalation adult child bronchospasm anaphylaxis acute asthma according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction according cpg registered medical practitioner instruction 36 177 tetanus immunoglobulin intramuscular adult child post exposure prophylaxis treatment tetanus infection according cpg registered medical practitioner instruction  given official seal 15 may 2020 simon harris minister health 177 37", "start_char": 31346, "end_char": 38187, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
{"doc_id": "si-2020-0177-explanatory-note", "parent_doc_id": "si-2020-0177", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 177 of 2020", "title": "(Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines", "year": 2020, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003 to make certain changes and additions to the lists of \nmedicinal products which may be supplied to pre-hospital emergency care \nproviders for use by advanced paramedics, paramedics and emergency medical \ntechnicians. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 2) Regulations 2020. \n\n \n \n \n \n \n \n\f38 [177] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-post: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€8.00 \n\n(DH-71) 75. 05/20. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 make certain change addition list medicinal product may supplied pre-hospital emergency care provider use advanced paramedic paramedic emergency medical technician regulation may cited medicinal product (prescription control supply) (amendment) (no 2) regulation 2020 38 177 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-post publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur8.00 (dh-71) 75 05 20 propylon", "start_char": 38187, "end_char": 39230, "source_path": "downloads\\2020\\2020_0176.pdf", "extraction_method": "pdfminer", "checksum": "sha256:a41eac531aee65e9341ecb55d0eed7b42fd69de2b621b822c4a9f5ce942628fd", "cross_refs": []}
